πŸ‡ΊπŸ‡Έ FDA
Patent

US 12329805

Dosage forms of tissue kallikrein 1

granted A61KA61K38/4853A61K45/06

Quick answer

US patent 12329805 (Dosage forms of tissue kallikrein 1) held by DiaMedica Inc. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DiaMedica Inc.
Grant date
Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/4853, A61K45/06, A61K9/0019, A61P